Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
Study sponsor: Glaukos Corporation
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-04-05Actual
Enrollment · participants590Actual
Source updated2024-11-29Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.